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Abstract
Introduction. Thoracic surgery is associated with high levels of pain.
Magnesium has antinociceptive effects in animal and human models of
pain.
Objectives. The aim of this randomized prospective study was to assess
the effects of continuous epidural magnesium infusion during thoracic
surgery on intraoperative sufentanil consumption and postoperative
analgesic requirements during the first 48 hours after surgery.
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Materials and methods. Seventy patients were randomized into two
groups of 35 patients: Group 1 (magnesium group) received an epidural
with 10% magnesium sulfate (MgSO4) along with anesthetic drugs
(midazolam, propofol, rocuronium, sufentanil, levobupivacain), and
group 2 (control group) received an epidural with 0.9% sodium chloride
(NaCl) solution along with anesthetic drugs intraoperatively.
Postoperatively, group 1 patients were administered the 10% magnesium
sulfate epidural in addition to a local anesthetic and opioid, whereas
group 2 patients were administered the local anesthetic and opioid alone.
Primary outcomes of the study were to determine the cumulative doses
of intraoperatively administered sufentanil and cumulative doses of
sufentanil and levobupivacaine administered during the first 48 h
postoperatively.
Secondary outcomes were a visual analog scale (VAS) score for rest and
movement every 4 hours, level of sedation, cardiovascular, respiratory
and neurological complications, incidence of postoperative shivering,
nausea and vomiting and global patient satisfaction.
Results. The cumulative sufentanil dose required intraoperatively was
significantly lower in the magnesium group: 43.00 μg vs 56.3 μg ( p =
0.001). VAS scores measured every 4 hours at rest and movement during
the first 48 hours postoperatively, cumulative analgesic consumption,
incidence of shivering, nausea and vomiting were significantly lower in
the magnesium group. The global satisfaction score was significantly
higher in the magnesium group (4.3 vs 3.7; p = 0.005).
Conclusion. The addition of magnesium in the epidural mixture of
sufentanil and levobupivacaine led to more efficient intraoperative and
postoperative analgesia, lower sufentanil and levobupivacaine
consumption, lower incidence of postoperative shivering, nausea and
vomiting. Epidural with magnesium appears to be a useful adjunct to
anesthetic drugs, which can exert positive effects on the course and
outcome of thoracic surgery patients.
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Patients undergoing surgical resection of the lungs are generally
classified, according to the American Society of Anesthesiology (ASA), as
class III, along with preoperatively impaired pulmonary function, mostly
coronary comorbidity, and compromised immune status due to
malignant and chronic lung diseases. (1)
Thoracic surgery is associated with severe painful stimuli.
Inadequate postoperative pain control leads to dysfunction of the
respiratory musculature, diaphragm in particular, causing
hypoventilation, hypoxia, atelectasis, pneumonia, coronary stress and
increases the rate of deep vein thrombosis and chronic postoperative
pain syndrome. (2)
Current treatment of postoperative pain should be prophylactic, i.e.
preemptive, based on the mechanisms induced by the operative
procedure (somatic and visceral nociceptive pain, neuropathic
component of pain, static and dynamic pain). (3)
Thoracic epidural multimodal preventive analgesia with administration
of local anesthetic and opioid generally ensures good intra- and
postoperative analgesia with minimal depression of the central nervous
system (CNS) and respiratory system. However, in thoracic surgery
patients, besides the additive effect, the addition of opioid to local
anesthetic may exert an array of dose-dependent undesired effects, e.g.,
impaired intestinal motility, nausea, vomiting, pruritus, decreased
coughing reflex and respiratory depression, in patients with impaired
pulmonary function in particular. (3)
The antinociceptive effect of magnesium is based on two mechanisms:
blockade of calcium entry in the cell (the basic mechanism of action) and
noncompetitive antagonizing the N-methyl-d-aspartate (NMDA)
receptors. Magnesium antagonizes NMDA receptors in the CNS. The
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other mechanism of magnesium action is reduction of catecholamine
release due to sympathetic stimulation, thus decreasing peripheral
sensitization of nociceptors in the stress response to operative procedure.
(4-6)
Trials with intrathecal and epidural magnesium administration have
shown that magnesium is a valuable adjuvant analgesic, but very few
data are available on its analgesic effects in lung resection surgery. (7-10)
The aim of the present study was to assess effects of continuous epidural
magnesium infusion during thoracic surgery on intraoperative sufentanil
consumption and postoperative analgesic requirements during first 48
hours after surgery.
Materials and methods
Ethical approval for this study (Ethical Committee N°380-59-1016-
13/195/86) was provided by the Ethical Committee of University of
Zagreb, School of Medicine,Zagreb, Croatia (Chairperson prof dr
Branimir Jakšić ) on 21st March, 2013.
This prospective placebo-controlled randomized study included 70 ASA
I-III patients undergoing elective thoracic surgery. Exclusion criteria
were patients with major liver or kidney impairment, neuromuscular
disease, II-III degree AV block, extreme obesity, and those exposed to
opioids and/or calcium channel blockers before surgery.
Seventy patients were randomized into two groups of 35 patients: group
1 (magnesium group) received an epidural with10% magnesium sulphate
(MgSO4) along with anesthetic drugs, and group 2 (control group)
received an epidural with 0.9% sodium chloride (NaCl) solution along
with anesthetic drugs intraoperative. Postoperatively, group 1 patients
were administered an epidural with 10% magnesium sulphate in addition
to local anesthetic and opioid, whereas group 2 patients were
administered local anesthetic and opioid alone.
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On preoperative examination, patients included in the study were
informed of the methods of pain intensity assessment, which included a
visual analog scale (VAS) for rest and movement. All study patients were
premedicated with 7.5 mg midazolam per os one hour before the
operation. In all patients, cardiovascular function was monitored by
electrocardiography (Datex-Ohmeda) and invasive blood pressure
measurement (Datex-Ohmeda), oxygenation by pulse oximeter (Datex-
Ohmeda), ventilation by capnography (Datex-Ohmeda), level of
neuromuscular blockade by a Train of Four (TOF) Guard
neurostimulator (Organon Tehnika), and level of hypnosis by bispectral
index (BIS) determination on a BIS monitor (Datex-Ohmeda).
Group 1 patients were injected 0.2 μg/kg sufentanil, 10 mg 0.5%
levobupivacaine and 50 mg 10% MgSO4 via epidural catheter (Th 4-Th
6) 15 minutes before induction of general anesthesia. Group 2 patients
were injected 0.2 μg/kg sufentanil and 10 mg 0.5% levobupivacaine via
epidural catheter (Th 4-Th 6) 15 minutes before induction of general
anesthesia. Anesthesia was induced with midazolam at a dose of 0.03
mg/kg, sufentanil 0.3 μg/kg and propofol 1 mg/kg. After the induction of
anesthesia, group 1 patients were administered continuous epidural
infusion of 10% MgSO4 at a dose of 10 mg/h, whereas group 2 patients
received the same volume of epidural 0.9% NaCl.
In all patients, neuromuscular blockade was achieved with muscle
relaxant rocuronium at a dose of 0.7 mg/kg to facilitate endotracheal
intubation. All patients were mechanically ventilated with 1:1 air/oxygen
mixture.
Hypnosis was maintained by continuous propofol infusion according to
BIS values 40-60, and myorelaxation according to TOF = 1 by continuous
rocuronium infusion. Intraoperative elevation of the mean blood
pressure and pulse by ≥20% of the initial values was defined as
inadequate analgesia. These patients received a sufentanil bolus dose of
0.2 μg/kg. At the end of the operation, propofol was discontinued on skin
closure and neuromuscular blockade was antagonized by the
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administration of 0.01 mg/kg atropine and 0.025 mg/kg neostigmin. The
patients were extubated when the BIS values reached 80 and the TOF
ratio was > 0.8.
During the first 48 h postoperatively in the intensive care unit, group 1
patients were administered a continuous infusion of sufentanil 1 μg/mL,
levobupivacaine 1 mg/mL and 10% MgSO4 1 mg/mL via epidural
catheter. In the same period, group 2 patients received a continuous
infusion of sufentanil 1 μg/mL and levobupivacaine 1 mg/mL via
epidural catheter. The value of VAS ≤3 was maintained by adjusting the
rate of infusion. The values of VAS score for rest and movement and the
level of sedation were determined every 4 hours. Patient’s global
satisfaction levels regarding comfort and quality of pain control were
assessed using a five-point scale.
Hemodynamic parameters (central venous pressure, non-invasive
systolic and diastolic blood pressure, heart rate) urine output and
respiratory rate were recorded 48 hours postoperatively. In addition
episodes of shivering and postoperative nausea and vomiting (PONV)
were recorded during the study period.
Primary outcomes of the study were to determine cumulative doses of
intraoperative administered sufentanil and cumulative doses of
sufentanil and levobupivacaine administered during 48 h
postoperatively.
Secondary outcomes were VAS score for rest and movement every 4
hours, level of sedation, cardiovascular, respiratory and neurological
complications, incidence of postoperative shivering, nausea and vomiting
and global patient satisfaction.
Statistics
Prior to statistical processing, continuous variables were tested for
normality of distribution by Kolmogorov-Smirnov test. Descriptive
values of continuous variables were expressed as arithmetic mean and
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standard deviation or median and interquartile range, as appropriate.
Values of categorical variables are shown as absolute and relative
frequencies.
The t-test for independent samples or its nonparametric alternative,
Mann-Whitney U test was employed to compare continuous variables
between the two study groups. Differences in categorical variables were
analysed by means of the χ2-test. The level of significance in all
procedures was set at p<0.05. Complete data processing was performed
using SPSS 17 for Windows statistical software (SPSS Inc., Chicago, IL,
USA).
Results
A total of 70 patients were enrolled in this study. The magnesium group
included 35 patients, 11 (31.4%) of them female and the control group 35
patients, 13 (37.1%) of them female.
The magnesium and control group were comparable for age, weight,
gender and duration of surgery (table 1).
The induction doses of sufentanil were similar and comparable in both
groups with p=0.228. Mean added sufentanil dose required
intraoperative was significantly lower in the magnesium group,
compared to controls (17.1 μg versus 31.9 μg; p< 0.001). The mean
cumulative dose of sufentanil was 43.00 μg in magnesium group and
56.3 μg in control group (p = 0.001) (figure 1).
VAS scores measured every 4 hours at rest and movement during the
first 48 hours postoperatively were significantly lower at all measured
intervals in the magnesium group (figures 2, 3).
Cumulative epidural dose of sufentanil during 48 h postoperatively was
significantly lower in magnesium group (208.2 +/- 41.19 μg), compared
to 341.25 +/- 48.43 μg in the control group I (p < 0.001). Same was true
for cumulative epidural dose of levobupivacain with mean dose of 202.5
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+/- 43.74 mg in magnesium group versus 331.26 +/- 70.46 mg in the
control group (p < 0.001).
Global satisfaction score was significantly higher in group 1 (4.3 versus
3.7, p = 0,005).
The two groups were similar in respect to hemodynamic parameters
during surgery.
Shivering was significantly less in group 1:4 patients versus 24 in group
2. The incidence of nausea and vomiting was also significantly less in
group 1, 6 patients versus 15 in group 2. Respiratory depression or
neurologic deficit was not observed in any patient. Hemodynamic
instability or any other cardiac problem possibly connected with
magnesium was not observed.
Discussion
The aim of this prospective double-blind placebo-controlled randomized
study was to assess the effect of epidural magnesium sulphate on
intraoperative and postoperative analgesia requirements, incidence of
postoperative nausea, vomiting and shivering, and postoperative level of
sedation in patients undergoing thoracic surgery . The large operative
wound after thoracotomy induces significant stimulation of the
mechanical high-threshold nociceptors, i.e. endings of the primary
afferent A-delta high-conductivity fibers in the skin and subcutaneous
tissue, leading to the occurrence of ‘pinching’ or ‘squeezing’ pain
(epicritic pain). This pain sensation is almost unbearable for patients on
deep breathing, when the skin in the incision area is tightened (dynamic
pain). Thoracotomy incision causes injury of the skin, soft tissue, muscle,
costovertebral and costotransverse ligaments, thus inducing strong and
prolonged stimulation of polymodal receptors. At thoracotomy, parietal,
visceral, mediastinal and diaphragmatic pleura is a considerable source
of strong nociception, which is classified as visceral nociceptive pain.
(1,2) The purpose of efficient postoperative pain management is to
ensure optimal analgesic effect without development of respiratory
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depression, pruritus, nausea and vomiting; therefore, adding to the
epidural mixture a drug that can reduce the analgesic dose of opioid is
highly welcome. In elderly patients and in those with chronic obstructive
pulmonary disease higher doses of opioid analgesic may increase the rate
of serious side effects. (3)
Our study showed that the cumulative dose of opioid administered
intraoperatively is significantly lower in group M patients as compared
with group C, either comparing the total dosage or dose per kg body
weight.
Total doses of levobupivacaine and sufentanil administered over 48 h
postoperatively were significantly lower in group M patients that
received magnesium in addition to sufentanil and levobupivacaine. The
patients administered magnesium sulphate had lower VAS values for
pain at rest and on coughing and movement throughout the 48-h period.
All these differences were statistically significant.
The presence of severe pain in the perioperative period is explained by
the activation of NMDA receptors on the dorsal horn with excitatory
transmitters (glutamate), which leads to the entry of Ca2+ ions in the cell
by initiating the cascade of central sensitization that is now believed to
cause the severe and prolonged postoperative pain. The NMDA receptor
is an amino acid receptor responsible for the excitatory synaptic
transmission and possessing the d+binding sites positive for the
excitatory amino acid glutamate and negative for ketamine or
magnesium. (4,5)
Magnesium blocks the entry of Ca ions in the cell and non-competitively
antagonizes NMDA receptor channels. As an NMDA antagonist,
magnesium leads to the voltage dependent blockade of NMDA receptor,
thus playing a major role in the prevention and treatment of the
intensive postoperative pain. (6)
Although the mechanism of interaction between NMDA receptors and
opioid antinociception has not yet been fully clarified, magnesium is
considered to enhance the analgesic effect of opioids and reduce the
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development of tolerance. (6)
One of the possible mechanisms for the analgesic action of epidural
magnesium is its diffusion through the dura. In the CNS, magnesium
reaches a concentration that is high enough to attenuate the function of
NMDA ionophores. It is magnesium bioavailability in the CNS that is
considered crucial for its action, since the intrathecal administration of
magnesium along with fentanyl significantly prolonged the duration of
analgesia versus fentanyl alone in the studies conducted by Buvanedran
et al. , Ozalevli et al. and Ulungenc et al. (8-10) In the study by Bilir et al.,
the addition of magnesium to the epidural mixture of fentanyl and local
anaesthetic significantly reduced total postoperative utilization of
fentanyl. (7)
The epidural doses of magnesium administered to our patients could be
presumed to have increased its cerebrospinal fluid (CSF) concentrations,
thus attenuating the electrophysiological sequels of NMDA receptor
activation. Another possible mechanism would imply the supraspinal
action of magnesium as a consequence of its systemic absorption. (11-13)
Numerous authors have investigated the effect of epidural and
intrathecal administration of magnesium on the use of opiates and
opioids and other analgesics in patients undergoing minor surgical
procedures associated with perioperative nociception of lower intensity
(gynaecologic, orthopaedic, ophthalmologic and daily surgery
procedures). (14-20) All these studies confirmed the efficacy of
magnesium in reducing postoperative pain intensity and opioid
requirements, while prolonging the duration of postoperative analgesia.
Gupta et al. investigated the impact of intravenous magnesium on
postoperative pain intensity and epidural analgesics fentanyl and
bupivacaine requirements in thoracic surgery patients undergoing lung
volume reduction surgery. Study results showed a significantly longer
duration of analgesia and reduced fentanyl and bupivacaine utilization in
the group of patients administered magnesium intravenously. (21)
Kim et al. evaluated the effects of epidural magnesium on the cumulative
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dose of ropivacain in patients, with patient controlled epidural analgesia
after thoracotomy, and concluded that magnesium showed no beneficial
effect in the early period after surgery. (22)
A study conducted by Kogler J. revealed the intravenous bolus doses of
fentanyl and the total dose of intravenous and epidural fentanyl,
administered intraoperative to thoracic surgery patients, to be
statistically significantly lower in the group of patients receiving
continuous intravenous infusion of magnesium. Pain intensity, as
determined by VAS did not differ significantly between the groups during
48 h, in particular during the first 24 h (p=0.409) postoperatively. The
lower absolute scale values on coughing and movement in patients
administered magnesium postoperatively pointed to the more efficient
control of dynamic pain, which can be influenced by magnesium via
NMDA receptor blockade. (23)
A search of the literature yielded only the study by Lee et al., who
investigated the effect of perioperative epidural magnesium on the rate of
chronic postoperative pain in thoracic surgery patients undergoing a
video-assisted thoracic surgery procedure. Study results failed to show a
lower incidence of chronic pain in this group of patients. (24)
In thoracotomy patients, the positive effects of reduced doses of local
anesthetics administered postoperatively contribute to better
hemodynamic stability, fast recovery of physiologic diaphragm
movements, increase the functional residual capacity and lung volume,
while maintaining the intercostal musculature strength necessary for
efficient expectoration. (22)
Therefore, we believe that the low doses of total levobupivacaine
administered postoperatively in our group of thoracic surgery patients,
who received magnesium in addition to sufentanil and levobupivacaine,
could had a favourable effect.
The results of our study indicate that satisfactory hemodynamic stability
was maintained in both patient groups, while systolic and diastolic
pressure and pulse values were comparable on all measurements and
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differences did not reach statistical significance.
In our study, the rate of postoperative nausea, vomiting, pruritus and
postoperative shivering was lower in the group of patients administered
magnesium. The difference pointed to the antiemetic action of
magnesium, or to an indirect effect because of the lower need of opioids
in the group of patients administered magnesium.
Shivering is an involuntary, oscillating muscular activity that stimulates
metabolic activity by the increased oxygen consumption and the
formation of carbon dioxide of up to 800% basal values. Postoperative
hypertension increases the intensity of sympathetic activity, peripheral
vascular resistance and the risk of myocardial ischemia, along with the
occurrence of dysrhythmias, in particular threatening patients with
existing ischemic heart disease and reduced respiratory reserve.
The sedation score did not differ significantly between the two groups.
There was no excessive drowsiness or respiratory depression in the group
of patients administered magnesium, which is consistent with the reports
by Bilir et al. and El Kerdawy et al. (7,14) We recorded no neurologic
complications that could be associated with epidural magnesium.
The magnesium safety profile relative to the CNS was evaluated in
experimental dog and rat models. Results showed the use of magnesium
to have prevented spinal injury in spite of severe ischemia, and did not
cause any histopathological lesions of neural structures.
Literature data show that accidental epidural administration of high
doses of magnesium (8.7-9.6 g) and intrathecal administration of 1000
mg caused no neurologic lesion except for transient motor blockade
(Goodman et al., Lejuste et al.). (25,26)
The present study limitation was the use of only one dose – response
evaluation, and lack of determination of cerebrospinal fluid magnesium
concentration as this was considered to be invasive.
Conclusion
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Results of the present study indicate that the addition of magnesium in
the epidural mixture of sufentanil and bupivacaine led to more efficient
intraoperative and postoperative analgesia and to lower utilization of
sufentanil and bupivacaine.
We observed a lower rate of nausea, vomiting, pruritus and postoperative
shivering.
The magnesium dosage used in the study was associated with normal
hemodynamic and respiratory status of patients.
We can conclude, that, based on the favorable effects recorded, epidural
magnesium appears to be a useful adjunct to anesthesiologic drugs,
which can exert positive effects on the course and outcome of thoracic
surgery procedures.
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Table 1. Demographic characteristics.
Parameter Mg Control p
Age (years; mean +/- SD) 58,7 +/-10,89
60,3 +/-
12,34 0,553*
Gender (N and % female) 11; 31,4% 13; 37,1% 0,615†
Body mass (kg; mean +/- SD) 74,3 +/-6,47
73,9 +/-
5,88 0,282*










Figure 1. Intraoperative sufentanil doses required.
Figure legend: white = Mg group; grey = control group
Figure 2. VAS score at rest during 48 h postoperatively.
Figure legend: black line = Mg group; grey dashed line = control group; *
p<0,05; ** p<0,001
Figure 3. VAS score at movement during 48 h postoperatively.
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Figure legend: black line = Mg group; grey dashed line = control group; *
p<0,05; ** p<0,001
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